Search results
UC San Francisco Scientists Find Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms...
Sierra Sun Times· 12 hours agoMay 6, 2024 - By Levi Gadye - In a discovery that could hasten treatment for patients with multiple ...
Molly Murray: Why don't we know more about autoimmune diseases? (Opinion)
The Charleston Gazette· 6 days agoImagine feeling unwell for months, years — even decades — and never knowing why. Imagine the anguish of not understanding the suffering taking place in your body and the frustration of it not ...
'Autoantibody Signature' Flags MS Years Before Symptoms
Medscape· 6 days agoA unique autoantibody signature of multiple sclerosis (MS) is detectable in the blood of people with...
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple ...
Medical Xpress· 12 hours agoIn individuals with multiple sclerosis (MS), abnormally active respiration in B cells drives pro-inflammatory responses of myeloid cells and T cells, leading ...
...Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed...
FOX 4 Kansas City· 7 days ago...IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that data from its phase 2 EMPhASIS trial of lead asset, vidofludimus calcium (IMU-838), in patients with...
‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound...
Fox News· 7 days agoResearchers may have hit "gold" when it comes to the treatment of multiple sclerosis. An...
Research shows interferon-beta regulates excessive alternative splicing in multiple sclerosis
Medical Xpress· 3 days agoA new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients compared to healthy controls ...
Finley siblings share their fight against Multiple Sclerosis, encourages people to get checked
KNDO - KNDU Tri-Cities· 6 days agoAccording to the National Multiple Sclerosis Society, almost one million Americans live with ...
Tolerizing vaccines for autoimmune diseases tempt BMS into $1.8bn collaboration
BioPharma-Reporter· 7 days agoBristol Myers Squibb (BMS) has bet up to $1.8bn in a collaboration with Repertoire Immune Medicines...
Immunic publishes extended data from Phase 2 MS trial in peer-reviewed journal
Proactive Investors· 7 days ago...NASDAQ:IMUX) has published extended data from its Phase 2 EMPhASIS trial of its lead asset...